If you’ve been battling the cost of living recently, spare a thought for those living in Hong Kong. According to ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
ANV-419 is under clinical development by Anaveon and currently in Phase II for Relapsed Multiple Myeloma. According to GlobalData, Phase II drugs for Relapsed Multiple Myeloma have a 31% phase ...
At the call of midnight on December 31 of the year 2024, Switzerland has put in the practice of a new burqa ban, and in this ...